India has experienced significant growth in intellectual property filings, with patents and industrial design filings ...
The US Court of Appeals for the Federal Circuit affirmed a district court determination that a patent owner had not provided the ...
Generate docx, pptx, and xlsx from templates (Word, Powerpoint and Excel documents), from Node.js or the browser. Demo: https://www.docxtemplater.com/demo. #docx # ...
According to IP firm Mathys & Squire, semiconductor patent applications worldwide spiked by 22 percent, jumping from 66,416 in 2022-23 to 80,892 in 2023-24. Leading the charge is China, whose filings ...
This week, OpenAI quietly published a statement on its website pledging not to use its patents offensively. Asserting its commitment to the principles of “broad access” and “collaboration ...
Further Solidifies International Patent Portfolio and Underscores the Company's Commitment to Innovation of SI Joint Stabilization Systems and Methods LOS GATOS, CA / ACCESSWIRE / October 17 ...
Dr. Mo Abolkheir, a philosopher specializing in inventions and patents, has identified a logical fallacy—a flawed argument that may appear valid but is based on faulty reasoning—within the law.
While Google Docs might be the first online word processor that comes to mind for most of us, it's by no means the only option out there on the web—and one of the best alternatives is the free ...
GSK says it owns seven patents that “provide the foundation” for Moderna’s messenger RNA vaccine portfolio, and is now suing the biotechnology company for infringement. At issue is the work of a team ...
Read our disclosure page to find out how can you help Windows Report sustain the editorial team Read more PowerPoint will enhance your presentations with improved template support based on Copilot.
GSK is "willing to license these patents on commercially reasonable terms and to ensure continued patient access," a company spokesperson said. The lawsuits add to a web of U.S. court cases ...
GSK sued Moderna over the shots in Delaware federal court Tuesday, claiming the mRNA specialist ignored GSK-owned patents related to lipid mRNA vaccine formulation technology. The lawsuits ...